Skip to content

Clinical trials

Completed Latent Tuberculosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Latent Tuberculosis Status: Completed Clear all

84 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20053
20061
20074
20084
20094
20105
20115
20123
20133
20144
20153
20163
20175
20183
20199
20204
20214
20226
20235
20242
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed84

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.3
Centers for Disease Control and Prevention3
Johns Hopkins University3
McGill University3
Queen Mary University of London3
Aeras2
Harvard School of Public Health (HSPH)2
Instituto Nacional de Salud Publica, Mexico2
McGill University Health Centre/Research Institute of the McGill University Health Centre2
National Institute of Allergy and Infectious Diseases (NIAID)2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Latent Tuberculosis84
Tuberculosis34
HIV Infections6
Tuberculosis Disease6
Acquired Immunodeficiency Syndrome5
Tuberculosis, Pulmonary4
Mycobacterium Infections3
Kidney Failure, Chronic2
Tuberculosis, Multidrug-Resistant2
Asthma1

Trials

Showing 26 to 50 of 84. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.